Orthofix Medical Inc.
OFIX
$16.30
-$0.46-2.75%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 215.66M | 196.61M | 198.62M | 188.61M | 200.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 215.66M | 196.61M | 198.62M | 188.61M | 200.42M |
| Cost of Revenue | 63.77M | 61.55M | 63.87M | 61.37M | 56.75M |
| Gross Profit | 151.89M | 135.05M | 134.75M | 127.24M | 143.67M |
| SG&A Expenses | 136.48M | 130.14M | 134.22M | 131.69M | 132.28M |
| Depreciation & Amortization | 4.34M | 4.55M | 4.32M | 6.57M | 4.32M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 223.40M | 213.54M | 220.46M | 219.12M | 212.29M |
| Operating Income | -7.74M | -16.93M | -21.84M | -30.51M | -11.88M |
| Income Before Tax | -29.71M | -26.64M | -32.36M | -35.17M | -22.05M |
| Income Tax Expenses | -564.00K | 751.00K | 1.08M | 851.00K | 125.00K |
| Earnings from Continuing Operations | -29.15M | -27.39M | -33.44M | -36.02M | -22.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.15M | -27.39M | -33.44M | -36.02M | -22.17M |
| EBIT | -7.74M | -16.93M | -21.84M | -30.51M | -11.88M |
| EBITDA | 19.55M | -141.00K | -6.30M | -14.17M | 5.08M |
| EPS Basic | -0.75 | -0.71 | -0.88 | -0.95 | -0.59 |
| Normalized Basic EPS | -0.41 | -0.40 | -0.48 | -0.60 | -0.24 |
| EPS Diluted | -0.75 | -0.71 | -0.88 | -0.95 | -0.59 |
| Normalized Diluted EPS | -0.41 | -0.40 | -0.48 | -0.60 | -0.24 |
| Average Basic Shares Outstanding | 38.70M | 38.49M | 38.02M | 37.74M | 37.30M |
| Average Diluted Shares Outstanding | 38.70M | 38.49M | 38.02M | 37.74M | 37.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
